Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) said late Thursday Q3 net loss was $0.39 per share on $4.4 million in sales. Analysts were looking for $3.71 million in sales and a loss of $0.31 per share, which usually is less items. Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) also said the U.S. Department of Defense has exercised an option with Canada's Tekmira Pharmaceuticals Corp for the company to make 500 courses of its experimental treatment for Ebola. Supplies of TKM-Ebola-Guinea will be available in early December, with plans to use it for clinical studies in West Africa, TKMR said. It was not clear if this supply was separate from the U.S. Department of Defense order.Ebix Inc (NASDAQ:EBIX) a supplier of On-Demand software and E-commerce services to the insurance, financial and healthcare industries, announced Q3 results that beat the Street view on EPS but missed on total revenues. Ebix Inc (NASDAQ:EBIX) reported Q3 adjusted EPS of $0.47, up from $0.34 a year ago and beating analyst estimates of $0.38. Total revenues of $50.80 million were up from $50.29 million in Q3 2013 but missed analyst projections of $51.75 million."While the revenues in the third quarter were negatively impacted by the lower transaction count in the Property & Casualty space in the Asia-Pacific region, we had a strong quarter in terms of new deals," Ebix Chairman, President and CEO Robin Raina said. "We agreed on four key deals with named carriers in the life space, for our TPP system, which we are expecting to begin generating recurring revenues beginning January of 2015." The company's Board of Directors has declared a quarterly dividend of $0.075 per share, consistent with the previous quarter's payout and payable December 15 to shareholders of record at the close of business on December 1. Shares of EBIX are at $14.71 within a 52-week range of $11.34 - $17.95.Cogent Communications Holdings Inc (NASDAQ:CCOI) Friday reported a net loss for Q3 ended September 30 as a result of increased operating expenses. But quarterly dividend has been raised by 3.3%. The provider of communications technology said net loss was $5.2 million, or nil per diluted share, versus a net income of $4.5 million, or $0.05 per diluted share, a year ago. Analysts were expecting a net income of $0.03 per diluted share, according to Capital IQ. The decline in earnings came from a jump in total operating expenses to $82.1 million from last year's $75.2 million. Service revenues totaled $95.7 million, an improvement from $87.8 million in 2013 but softer than the mean estimate of $96.96 million.Despite results, the board of directors approved a 3.3% increase in the regular quarterly dividend to $0.31 per common share from the previous $0.30 per share, to be paid December 12 to shareholders of record on November 26. Cogent Communications Holdings Inc (NASDAQ:CCOI) finished higher on Thursday at $32.82 each, within a 52-week range of $29.70 - $43.50.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
